Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2022		34,026
Beginning Balance at Dec. 31, 2022	$ 1,681,721	$ 340	$ 0	$ 1,858,103	$ (176,722)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	274,892			274,892
Comprehensive (Loss) Income
Cumulative translation adjustment	26,262				26,262
Issuance of common stock in connection with:
Exercise of options (in shares)		38
Exercise of options	1,297		1,297
Restricted share grants (in shares)		108
Restricted share grants	(14,100)	$ 1	(14,101)
Settlement of conversion premium of convertible senior notes due 2023 (in shares)		1,461
Settlement of conversion premium of convertible senior notes due 2023	(6)	$ 15	(21)
Purchase and retirement of common stock (in shares)		(112)
Purchase and retirement of common stock	(17,799)	$ (1)	(17,798)
Conversion of convertible senior notes due 2023	(381)		(381)
Share-based compensation	29,534		29,534
Reclassification of negative additional paid-in capital	0		18,230	(18,230)
Ending Balance (in shares) at Dec. 31, 2023		35,521
Ending Balance at Dec. 31, 2023	1,981,420	$ 355	16,760	2,114,765	(150,460)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	280,088			280,088
Comprehensive (Loss) Income
Cumulative translation adjustment	(26,112)				(26,112)
Issuance of common stock in connection with:
Exercise of options (in shares)		294
Exercise of options	10,891	$ 3	10,888
Restricted share grants (in shares)		150
Restricted share grants	(16,216)	$ 2	(16,218)
Purchase and retirement of common stock (in shares)		(52)
Purchase and retirement of common stock	(10,217)	$ (1)	(10,216)
Share-based compensation	$ 38,436		38,436
Ending Balance (in shares) at Dec. 31, 2024	35,913	35,913
Ending Balance at Dec. 31, 2024	$ 2,258,290	$ 359	39,650	2,394,853	(176,572)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	270,871			270,871
Comprehensive (Loss) Income
Cumulative translation adjustment	$ 46,968				46,968
Issuance of common stock in connection with:
Exercise of options (in shares)	38	38
Exercise of options	$ 1,387	$ 0	1,387
Restricted share grants (in shares)		178
Restricted share grants	(16,477)	$ 2	(16,479)
Purchase and retirement of common stock (in shares)		(5,265)
Purchase and retirement of common stock	(866,632)	$ (52)	(866,580)
Share-based compensation	39,324		39,324
Reclassification of negative additional paid-in capital	$ 0		803,052	(803,052)
Ending Balance (in shares) at Dec. 31, 2025	30,864	30,864
Ending Balance at Dec. 31, 2025	$ 1,733,731	$ 309	$ 354	$ 1,862,672	$ (129,604)